je.st
news
Tag: cell
Air Liquide forms JV with Toyota Tsusho for hydrogen supply for fuel cell electric vehicles
2013-10-30 14:30:11| Green Car Congress
StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio
2013-10-30 05:24:33| drugdiscoveryonline News Articles
StemCells, Inc. (Nasdaq:STEM) today announced the acquisition of a portfolio of issued US and Canadian patents to which it had previously held an exclusive worldwide license
Tags: cell
portfolio
stem
patent
ZTE Selects Freescale's QorIQ Qonverge Small Cell Technology For TD-LTE Deployment
2013-10-29 07:55:02| wirelessdesignonline News Articles
ZTE Corporation, a top global provider of telecommunications equipment and network solutions, has selected Freescale’s QorIQ QonvergeBSC9132 “base station-on-chip” product to power one of the first ever commercial deployments based on the LTE standards.
Tags: small
technology
cell
deployment
ZTE Selects Freescale's QorIQ Qonverge Small Cell Technology For TD-LTE Deployment
2013-10-29 07:55:02| rfglobalnet News Articles
ZTE Corporation, a top global provider of telecommunications equipment and network solutions, has selected Freescale’s QorIQ QonvergeBSC9132 “base station-on-chip” product to power one of the first ever commercial deployments based on the LTE standards.
Tags: small
technology
cell
deployment
Merck Announces Presentation of Interim Data from Phase 1B Study of MK-3475, Investigational anti-PD-1 Immunotherapy, in Previously-Treated Patients with Non-Small Cell Lung Cancer (NSCLC) at 15th World Conference on Lung Cancer
2013-10-29 06:15:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. Phase II/III Trial of MK-3475 in Patients with NSCLC Currently Enrolling WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of interim data from a Phase 1B trial (PN001) evaluating MK-3475, an investigational anti-PD-1 immunotherapy, in patients with previously-treated non-small cell lung cancer (NSCLC). The data were presented today by Dr. Language: English Contact: MerckMedia Contacts:Ian McConnell, 908-423-3046orClaire Mulhearn, 908-423-7425orInvestor Contacts:Carol Ferguson, 908-500-1101orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [281] [282] [283] [284] [285] [286] [287] [288] [289] [290] [291] [292] [293] [294] [295] [296] [297] [298] [299] [300] next »